Suspension of trading

DiaSys Corporation Stock

Stocks

DYXC

US2528381070

Advanced Medical Equipment & Technology

OTC Markets Traded
Delayed OTC Markets 17:44:37 08/07/2025 +04 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for DiaSys Corporation -.--% -

Valuation: DiaSys Corporation

Market Cap 51.44K 45.12K 41.79K 38.45K 72.73K 4.92M 74.14K 498K 195K 2.42M 193K 189K 8.35M P/E 2006
-3.78x
P/E 2007 -3x
Enterprise Value 646K 566K 525K 483K 913K 61.81M 931K 6.25M 2.45M 30.36M 2.43M 2.37M 105M EV / Sales 2006
2.7x
EV / Sales 2007 2.04x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+0.48%+2.62%+24.88%+0.86% 196B
+0.73%-5.19%-20.54%+18.27% 144B
+0.38%+3.29%+1.13%-16.26% 141B
+0.11%+0.53%-57.03%-15.07% 66.54B
-0.46%-3.46%+17.38%-1.29% 53.09B
+2.80%+1.95%-22.68%-30.55% 44.12B
-0.84%+2.19%+11.14%+11.82% 37.93B
-0.96%-1.33%+22.90%+38.84% 36.96B
+1.18%+1.25%-11.82%-19.35% 29.43B
Average +0.30%-0.68%-3.85%-1.41% 74.89B
Weighted average by Cap. +0.43%-0.83%-1.17%-0.79%

Financials

2006 2007
Net sales 1.69M 1.48M 1.37M 1.26M 2.39M 162M 2.43M 16.34M 6.41M 79.34M 6.34M 6.2M 274M 1.68M 1.47M 1.36M 1.25M 2.37M 161M 2.42M 16.25M 6.37M 78.88M 6.3M 6.16M 272M
Net income -1.05M -919K -851K -783K -1.48M -100M -1.51M -10.14M -3.98M -49.25M -3.93M -3.85M -170M -785K -689K -638K -587K -1.11M -75.16M -1.13M -7.6M -2.98M -36.91M -2.95M -2.88M -127M
Net Debt 302K 265K 245K 226K 427K 28.9M 435K 2.92M 1.15M 14.19M 1.13M 1.11M 49.02M 594K 521K 483K 444K 840K 56.89M 857K 5.76M 2.26M 27.94M 2.23M 2.18M 96.48M
Logo DiaSys Corporation
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Employees
10
  1. Stock Market
  2. Stocks
  3. DYXC Stock